ARID1A and hepatocellular carcinoma: To determine potential cross-talk among TET2 and other epigenetic modulators, we examined the RNA-seq results of TET2 knockout HCC cells and found that among diverse epigenetic factors, KMT2D and ARID1A are strikingly decreased upon deletion of TET2 (Fig. 1A).